P017 Melanoma
DESCRIPTION
Our understanding of melanoma biology, risk, and diagnosis continues to evolve rapidly. This session will cover topics ranging from the potential roles and innovation opportunities presented by diagnostic technologies, genomics, and innovative therapeutic approaches in melanoma diagnosis and management.
LEARNING OBJECTIVES
Define the role of genetics in melanoma risk.
Describe the role of novel technologies in the diagnosis of melanoma.
Examine optimal use of gene expression profile testing in melanoma.
SCHEDULE
8:45 AM
Update in Germline Genetics in Melanoma
Joshua Arbesman, MD, FAAD
9:00 AM
Total Body Photography
Nadeem Georg Marghoob, DO, FAAD
9:15 AM
AI in Melanoma Diagnosis
9:30 AM
Mohs for Melanoma
Abigail Baird Waldman, MD, FAAD
10:00 AM
Systemic Therapy in Melanoma: What Dermatologists Should Know
Rebecca I. Hartman, MD, MPH, FAAD
10:15 AM
Cutaneous Toxicity of Melanoma Therapies
Cuong Nguyen, MD, FAAD
10:30 AM
Q&A
DIRECTOR
Rebecca I. Hartman, MD, MPH, FAAD
Brigham and Women's Hospital
SPEAKERS
Joshua Arbesman, MD, FAAD
Edmund Bartlett
Memorial Sloan Kettering Cancer Center
Nadeem Georg Marghoob, DO, FAAD
Cuong Nguyen, MD, FAAD
Abigail Baird Waldman, MD, FAAD
Brigham and Women's Hospital, Harvard Medical School
DISCLOSURES
Joshua Arbesman, MD, FAAD
Castle Biosciences, Inc – Investigator(Grants/Research Funding); Celldex – Investigator(Grants/Research Funding); Clinuvel – Investigator(Grants/Research Funding); Curio Science LLC – Speaker/Faculty Education(Honoraria); DermaDetect – Advisory Board(Stock Options); Disc Medicine – Advisory Board(Honoraria); Merck & Co., Inc – Advisory Board(Honoraria); OpenEvidence – Consultant (1099 relationship)(Honoraria); Regeneron – Investigator(Grants/Research Funding); Sanotize – Stockholder Private Company(Stock); Variant Bio – Investigator(Grants/Research Funding);
Edmund Bartlett
QBiotics Group – Advisory Board(Honoraria), Investigator(Grants/Research Funding); SkylineDx – Investigator(Grants/Research Funding);
Rebecca I. Hartman, MD, MPH, FAAD
Almirall – Consultant (1099 relationship)(Fees); Evereden – Advisory Board(Stock), Consultant(Fees); Lumo Imaging – Advisory Board(No Compensation Received); Med Learning Group – Speaker/Faculty Education(Fees); MJH Life Sciences – Consultant (1099 relationship)(Fees); Moderna Therapeutics – Speaker(Fees); Prime Education – Speaker/Faculty Education(Fees); Veriskin – Investigator(Grants/Research Funding); Vita Imaging – Investigator(Grants/Research Funding); Zura Bio – Data Safety Monitoring Board(Fees);
Nadeem Georg Marghoob, DO, FAAD
No financial relationships exist with ineligible companies.
Cuong Nguyen, MD, FAAD
No financial relationships exist with ineligible companies.
Abigail Baird Waldman, MD, FAAD
No financial relationships exist with ineligible companies.